These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 7505120
1. Solid-phase von Willebrand factor contains a conformationally active RGD motif that mediates endothelial cell adhesion through the alpha v beta 3 receptor. Denis C, Williams JA, Lu X, Meyer D, Baruch D. Blood; 1993 Dec 15; 82(12):3622-30. PubMed ID: 7505120 [Abstract] [Full Text] [Related]
2. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins. Lu X, Williams JA, Deadman JJ, Salmon GP, Kakkar VV, Wilkinson JM, Baruch D, Authi KS, Rahman S. Biochem J; 1994 Dec 15; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494 [Abstract] [Full Text] [Related]
3. Relative importance of the glycoprotein Ib-binding domain and the RGD sequence of von Willebrand factor for its interaction with endothelial cells. Perrault C, Lankhof H, Pidard D, Kerbiriou-Nabias D, Sixma JJ, Meyer D, Baruch D. Blood; 1997 Sep 15; 90(6):2335-44. PubMed ID: 9310484 [Abstract] [Full Text] [Related]
4. Characterization of the novel murine monoclonal anti-von Willebrand factor (vWf) antibody GUR76-23 which inhibits vWf interaction with alpha IIb beta 3 but not alpha v beta 3 integrin. Yokoyama K, Handa M, Oda A, Katayama M, Fujimura Y, Murata M, Kawai Y, Watanabe K, Ikeda Y. Biochem Biophys Res Commun; 1997 May 08; 234(1):147-52. PubMed ID: 9168979 [Abstract] [Full Text] [Related]
5. Conformational changes in the A3 domain of von Willebrand factor modulate the interaction of the A1 domain with platelet glycoprotein Ib. Obert B, Houllier A, Meyer D, Girma JP. Blood; 1999 Mar 15; 93(6):1959-68. PubMed ID: 10068669 [Abstract] [Full Text] [Related]
6. Comparison of disintegrins with limited variation in the RGD loop in their binding to purified integrins alpha IIb beta 3, alpha V beta 3 and alpha 5 beta 1 and in cell adhesion inhibition. Pfaff M, McLane MA, Beviglia L, Niewiarowski S, Timpl R. Cell Adhes Commun; 1994 Dec 15; 2(6):491-501. PubMed ID: 7538018 [Abstract] [Full Text] [Related]
7. Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodies. Girma JP, Kalafatis M, Piétu G, Lavergne JM, Chopek MW, Edgington TS, Meyer D. Blood; 1986 May 15; 67(5):1356-66. PubMed ID: 3008890 [Abstract] [Full Text] [Related]
8. Glycoprotein Ib can mediate endothelial cell attachment to a von Willebrand factor substratum. Beacham DA, Cruz MA, Handin RI. Thromb Haemost; 1995 Feb 15; 73(2):309-17. PubMed ID: 7792748 [Abstract] [Full Text] [Related]
17. Agkistin, a snake venom-derived glycoprotein Ib antagonist, disrupts von Willebrand factor-endothelial cell interaction and inhibits angiogenesis. Yeh CH, Wang WC, Hsieh TT, Huang TF. J Biol Chem; 2000 Jun 23; 275(25):18615-8. PubMed ID: 10779501 [Abstract] [Full Text] [Related]
18. Adhesion of blood platelets is inhibited by VCL, a recombinant fragment (leucine504 to lysine728) of von Willebrand factor. Sixma JJ, Ijsseldijk MJ, Hindriks G, van Zanten GH, Gorecki M, Panet A, Garfinkel LI, de Groot PG. Arterioscler Thromb Vasc Biol; 1996 Jan 23; 16(1):64-71. PubMed ID: 8548428 [Abstract] [Full Text] [Related]